Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation (Details Narrative)

v3.21.2
Stock-Based Compensation (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
May 11, 2021
Apr. 09, 2021
Jan. 06, 2021
Aug. 12, 2020
Aug. 01, 2020
Jul. 15, 2020
Jul. 14, 2020
Jul. 03, 2020
Sep. 14, 2015
Jun. 30, 2021
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Mar. 02, 2021
Sep. 14, 2017
Sep. 14, 2016
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Number of fully vested option exercisable                     1,710,417   1,710,417        
Number of warrants to purchase common stock                             113,310    
Warrants exercise price                             $ 3.70    
Number of warrants outstanding acquire common stock                     3,110,310   3,110,310        
Stock price per share     $ 2.8566                            
Stock option vested exercisable term     5 years                   21 years        
Stock options are exercisable price per share     $ 3.21                            
Fair value of stock options     $ 571,312                            
Stock based compensation                     $ 347,222 $ 1,064,746 $ 1,854,058 $ 1,064,746      
Total deferred compensation expense for outstanding value of unvested stock options                         2,444,000        
Intrinsic value of exercisable but unexercised in-the-money stock options                     $ 66,000   $ 66,000        
Fair market value, per share                         $ 2.08        
Outstanding stock options to acquire shares of common stock not vested                     756,250   756,250        
DrWinson Sze Chun Ho [Member]                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Number of fully vested option issued     50,000                            
Dr. Yun Yen [Member]                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Number of fully vested option issued     50,000                            
DrStephen Forman [Member]                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Number of fully vested option issued     50,000                            
Philip Palmedo [Member]                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Number of fully vested option issued     50,000                            
MsRegina Brown [Member] | General and Administrative Expense [Member]                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Stock based compensation                     $ 38,827   $ 389,117        
BioPharmaWorks LLC [Member] | Collaboration Agreement [Member]                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Number of warrants to purchase common stock                 166,667                
Number of warrants to purchase common stock per warrant                 83,333.5                
Warrant exercisable term                               5 years 5 years
Warrants exercise price                               $ 12.00 $ 6.00
Stock options fully vested amount, fair value                 $ 670,715                
Stock price per share                 $ 4.0242                
Eric Forman [Member] | General and Administrative Expense [Member]                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Stock based compensation                     25,259 113,667 74,954 113,667      
Eric Forman [Member] | Employment Agreement [Member]                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Stock options fully vested amount, fair value       $ 100,214                          
Stock price per share           $ 6.8718                      
Stock options description           On July 15, 2020, as amended on August 12, 2020, in connection with the employment agreement entered into with Eric J. Forman, Mr. Forman was granted options for 58,333 shares of the Company’s common stock. The options can be exercised on a cashless basis. The options have a term of five years and an exercise price of $7.14 per share, which was equal to the closing market price of the Company’s common stock on the grant date. The options vested as to 25% on August 12, 2020 and August 12, 2021, and will vest 25% on each of the second and third anniversaries of the grant date. The fair value of these stock options, as calculated pursuant to the Black-Scholes option-pricing model, was determined to be $400,855 ($6.8718 per share), of which $100,214 was attributable to the stock options fully-vested on August 12, 2020 and was therefore charged to operations on that date. The remaining unvested portion of the fair value of the stock options is being charged to operations ratably from August 12, 2020 through August 12, 2023. During the three months ended September 30, 2021 and 2020, the Company recorded charges to general and administrative costs in the consolidated statement of operations of $25,259 and $113,667, respectively, with respect to these stock options. During the nine months ended September 30, 2021 and 2020, the Company recorded charges to general and administrative costs in the consolidated statement of operations of $74,954 and $113,667, respectively, with respect to these stock options.                      
Stock options granted to purchase common stock, issued           58,333                      
Stock option vested exercisable term           5 years                      
Stock options are exercisable price per share           $ 7.14                      
Fair value of stock options           $ 400,855                      
Dr. James Miser [Member] | General and Administrative Expense [Member]                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Stock based compensation                     36,085 166,697 107,078 166,697      
Dr. James Miser [Member] | Employment Agreement [Member]                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Stock options fully vested amount, fair value         $ 143,163                        
Stock price per share         $ 6.8718                        
Stock options description         Dr. James S. Miser, M.D., Dr. Miser was granted options for 83,334 shares of the Company’s common stock. The options can be exercised on a cashless basis. The options have a term of five years and an exercise price of $7.14 per share, which was equal to the closing market price of the Company’s common stock on the effective date of the employment agreement. The options vested as to 25% on August 1, 2020 and August 1, 2021, and will vest 25% on each of the second and third anniversaries of the effective date. The fair value of these stock options, as calculated pursuant to the Black-Scholes option-pricing model, was determined to be $572,650 ($6.8718 per share), of which $143,163 was attributable to the stock options fully-vested on August 1, 2020 and was therefore charged to operations on that date. The remaining unvested portion of the fair value of the stock options is being charged to operations ratably from August 1, 2020 through August 1, 2023. During the three months ended September 30, 2021 and 2020, the Company recorded charges to general and administrative costs in the consolidated statement of operations of $36,085 and $166,697, respectively, with respect to these stock options. During the nine months ended September 30, 2021 and 2020, the Company recorded charges to general and administrative costs in the consolidated statement of operations of $107,078 and $166,697, respectively, with respect to these stock options.                        
Stock options granted to purchase common stock, issued         83,334                        
Stock option vested exercisable term         5 years                        
Stock options are exercisable price per share         $ 7.14                        
Fair value of stock options         $ 572,650                        
Robert N. Weingarten [Member] | General and Administrative Expense [Member]                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Stock based compensation                     25,259 $ 113,667 74,954 $ 113,667      
Robert N. Weingarten [Member] | Employment Agreement [Member]                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Stock options fully vested amount, fair value       $ 100,214                          
Stock price per share       $ 6.8718                          
Stock options description       On August 12, 2020, in connection with the employment agreement entered into with Robert N. Weingarten, Mr. Weingarten was granted options for 58,333 shares of the Company’s common stock. The options can be exercised on a cashless basis. The options have a term of five years and an exercise price of $7.14 per share, which was equal to the closing market price of the Company’s common stock on the grant date. The options vested as to 25% on August 12, 2020 and August 12, 2021, and will vest 25% on each of the second and third anniversaries of the grant date. The fair value of these stock options, as calculated pursuant to the Black-Scholes option-pricing model, was determined to be $400,855 ($6.8718 per share), of which $100,214 was attributable to the stock options fully-vested on August 12, 2020 and was therefore charged to operations on that date. The remaining unvested portion of the fair value of the stock options is being charged to operations ratably from August 12, 2020 through August 12, 2023. During the three months ended September 30, 2021 and 2020, the Company recorded charges to general and administrative costs in the consolidated statement of operations of $25,259 and $113,667, respectively, with respect to these stock options. During the nine months ended September 30, 2021 and 2020, the Company recorded charges to general and administrative costs in the consolidated statement of operations of $74,954 and $113,667, respectively, with respect to these stock options.                          
Stock options granted to purchase common stock, issued       58,333                          
Stock option vested exercisable term       5 years                          
Stock options are exercisable price per share       $ 7.14                          
Fair value of stock options       $ 400,855                          
DrWinson Sze Chun Ho [Member] | General and Administrative Expense [Member]                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Stock based compensation                     42,692   457,543        
DrWinson Sze Chun Ho [Member] | Employment Agreement [Member]                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Stock options fully vested amount, fair value   $ 376,800                              
Stock price per share   $ 3.0144                              
Fair value of stock options   $ 753,611                              
Non Officer Directors [Member]                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Stock based compensation                     $ 179,100   $ 179,100        
Non Officer Directors [Member]                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Number of fully vested option exercisable   100,000               100,000              
Stock price per share   $ 2.84225                              
Stock option vested exercisable term                   5 years              
Stock options are exercisable price per share                   $ 3.03              
Fair value of stock options                   $ 1,421,095              
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Period Increase (Decrease)                   500,000              
Director [Member]                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Number of fully vested option issued     200,000                            
Director [Member] | MsRegina Brown [Member]                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Number of fully vested option exercisable 250,000 250,000                              
Stock options fully vested amount, fair value $ 329,188                                
Stock price per share $ 2.6335                                
Stock option vested exercisable term 5 years                                
Stock options are exercisable price per share $ 2.80                                
Fair value of stock options $ 658,363                                
Director [Member] | DrWinson Sze Chun Ho [Member]                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Number of fully vested option exercisable   250,000                              
Stock option vested exercisable term   5 years                              
Stock options are exercisable price per share   $ 3.20                              
Board of Directors Chairman [Member]                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Number of warrants outstanding acquire common stock               166,667                  
Warrants term, description               September 14, 2020 to September 14, 2025                  
Closing stock price of warrants                 $ 5.40                
2020 Stock Incentive Plan [Member]                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Number of fully vested option exercisable                     1,400,000   1,400,000        
2020 Stock Incentive Plan [Member] | Maximum [Member]                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Number of restricted stock issued             2,333,333